Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2024

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2024

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2024 – By Drug Type (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types), By Service Type (Target Identification And Validation, Lead Screening And Characterization, Cell-based Assays), By Therapeutic Area (Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas) – Market Size, Trends, And Global Forecast 2024-2033

Name: Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2024

Proud Members Of

Cancer Immunotherapy Drug Discovery Outsourcing Market Definition

Cancer immunotherapy drug discovery outsourcing is a specialized service model in the pharmaceutical and biotech sectors. It entails delegating aspects of cancer immunotherapy drug development to external service providers, typically contract research organizations (CROs) or contract development and manufacturing organizations (CDMOs) to speeds up innovation by leveraging external expertise and resources, letting pharmaceutical companies focus on core activities.

The main drug types of cancer immunotherapy drug discovery outsourcing are monoclonal antibodies, immunomodulators, oncolytic viral therapies and cancer vaccines, and others. Monoclonal antibodies refers to laboratory-made molecules that mimic the immune system's ability to fight off harmful pathogens by targeting specific proteins on cancer cells. The services include target identification and validation, lead screening and characterization, and cell-based assays used in therapeutic areas such as lung cancer, breast cancer, melanoma, and others.

Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation

The cancer immunotherapy drug discovery outsourcing market covered in this report is segmented –

1) By Drug Type: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types

2) By Service Type: Target Identification And Validation, Lead Screening And Characterization, Cell-based Assays

3) By Therapeutic Area: Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023 to 2028: Graph

Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2024 And Growth Rate

The cancer immunotherapy drug discovery outsourcing market size has grown rapidly in recent years. It will grow from $1.35 billion in 2023 to $1.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing cases of adverse drug reactions, increasing demand for comprehensive genomic testing, increasing global incidence of cancer, a growing need for targeted therapy, and a growing number of clinical trials.

Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Forecast

The cancer immunotherapy drug discovery outsourcing market size is expected to see rapid growth in the next few years. It will grow to $2.31 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to the rising importance of personalized medicine, increasing diagnostic tests, increasing focus on personalized cancer therapy, increasing healthcare expenditure, and increasing cancer incidence and awareness. Major trends in the forecast period include advancements in diagnostic technologies, next-generation sequencing (NGS), integration of artificial intelligence (AI), liquid biopsy technologies, the development of point-of-care companion diagnostic devices, and innovative testing technologies.

Book your 30 minutes free consultation with our research experts

Cancer Immunotherapy Drug Discovery Outsourcing Market Driver: High R&D Costs Fueling Growth in Cancer Immunotherapy Drug Discovery Outsourcing Market

The high cost of research and development is expected to propel the growth of the cancer immunotherapy drug discovery outsourcing market going forward. The high cost research and development is primarily due to the need for specialized expertise, expensive equipment, and the inherent risks involved in innovation. Outsourcing drug discovery activity leverages economies of scale offered by contract research organizations (CROs), enabling smaller biotech firms and startups to optimize their R&D budgets and allocate resources more efficiently, enhancing cost-effectiveness. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical R&D expenditure in Europe accounted for $49,500 million (€44,500 million) in 2022, an increase of approximately 6.45% from $46,500 million (€42,533 million) in 2021. Therefore, the high cost of in-house research and development is driving the growth of the cancer immunotherapy drug discovery outsourcing market.

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Major Players

Major companies operating in the cancer immunotherapy drug discovery outsourcing market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc, ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Jubilant Biosys, Oncodesign Services, Icagen Inc., Reaction Biology Corporation, ChemBridge Corporation

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Trend: Strategic Partnerships Driving Cancer Immunotherapy Drug Discovery Outsourcing

Major companies operating in the cancer immunotherapy drug discovery outsourcing market are adopting a strategic partnership approach to support the production of cancer drugs and gain a competitive advantage. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in February 2022, Ono Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, and Bristol-Myers Squibb, a US-based biopharmaceutical company, entered into an outsourcing agreement with Prime Research Institute for Medical Research, Inc., a Japan-based research institute, for a collaborative clinical research project focused on gastric cancer patients treated with Opdivo (nivolumab) in combination with chemotherapy. This industry-sponsored initiative involves a large-scale, multi-institutional study utilizing PRiME-R's data input support system called "CyberOncology," which facilitates the standardization, structuring, management, and integration of real-world data in routine cancer clinical practice. This clinical research, utilizing CyberOncology, evaluates Opdivo combined with chemotherapy for untreated advanced or recurrent gastric cancer. It involves about 30 medical institutions nationwide and aims to streamline data input, enhance data accuracy, and expedite analysis.

Cancer Immunotherapy Drug Discovery Outsourcing Market Merger And Acquisition: Strategic Acquisition Expands Charles River Laboratories' Cell And Gene Therapy Capabilities

In February 2021, Charles River Laboratories, a US-based pharmaceutical company specializing in drug delivery products and services, acquired Cognate BioServices for $875 million. The acquisition will enable Charles River to enhance its cell and gene therapy development, testing, and manufacturing capabilities while also complementing its current range of non-clinical services, thereby providing clients with comprehensive solutions spanning from initial research and discovery to CGMP production. Cognate BioServices is a US-based contract manufacturing company producing cellular immunotherapy and immune-oncology products.

Regional Outlook For The Global Cancer Immunotherapy Drug Discovery Outsourcing Market

North America was the largest region in the cancer immunotherapy drug discovery outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer immunotherapy drug discovery outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer immunotherapy drug discovery outsourcing market includes revenues earned by entities by providing services such as preclinical testing, clinical trial support, and biomarker discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cancer immunotherapy drug discovery outsourcing market research report is one of a series of new reports from The Business Research Company that provides cancer immunotherapy drug discovery outsourcing market statistics, including cancer immunotherapy drug discovery outsourcing industry global market size, regional shares, competitors with a cancer immunotherapy drug discovery outsourcing market share, detailed cancer immunotherapy drug discovery outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the cancer immunotherapy drug discovery outsourcing industry. This cancer immunotherapy drug discovery outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cancer Immunotherapy Drug Discovery Outsourcing Market Report Forecast and Analysis

Report Attribute	Details
Market Size Value In 2024	$1.5 billion
Revenue Forecast In 2033	$2.31 billion
Growth Rate	CAGR of 11.4% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Drug Type: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types 2) By Service Type: Target Identification And Validation, Lead Screening And Characterization, Cell-based Assays 3) By Therapeutic Area: Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc, ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Jubilant Biosys, Oncodesign Services, Icagen Inc., Reaction Biology Corporation, ChemBridge Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Cancer Immunotherapy Drug Discovery Outsourcing Market Characteristics

3. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends And Strategies

4. Cancer Immunotherapy Drug Discovery Outsourcing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Growth

5.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation

6.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Monoclonal Antibodies

Immunomodulators

Oncolytic Viral Therapies And Cancer Vaccines

Other Drug Types

6.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Target Identification And Validation

Lead Screening And Characterization

Cell-based Assays

6.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Lung Cancer

Breast Cancer

Melanoma

Other Therapeutic Areas

7. Cancer Immunotherapy Drug Discovery Outsourcing Market Regional And Country Analysis

7.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market

8.1. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cancer Immunotherapy Drug Discovery Outsourcing Market

9.1. China Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

9.2. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cancer Immunotherapy Drug Discovery Outsourcing Market

10.1. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market

11.1. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

11.2. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market

12.1. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market

13.1. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market

14.1. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

14.2. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market

15.1. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

15.2. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cancer Immunotherapy Drug Discovery Outsourcing Market

16.1. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market

17.1. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cancer Immunotherapy Drug Discovery Outsourcing Market

18.1. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market

19.1. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market

20.1. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market

21.1. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

21.2. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market

22.1. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market

23.1. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

23.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cancer Immunotherapy Drug Discovery Outsourcing Market

24.1. USA Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

24.2. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market

25.1. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

25.2. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cancer Immunotherapy Drug Discovery Outsourcing Market

26.1. South America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

26.2. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market

27.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market

28.1. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

28.2. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market

29.1. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

29.2. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape And Company Profiles

30.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape

30.2. Cancer Immunotherapy Drug Discovery Outsourcing Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Danaher Corporation

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Laboratory Corporation of America Holdings (LabCorp)

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Eurofins Scientific SE

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. WuXi AppTec Co Ltd.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Cancer Immunotherapy Drug Discovery Outsourcing Market Other Major And Innovative Companies

31.1. Charles River Laboratories International Inc.

31.2. PerkinElmer Inc

31.3. Bio-Rad Laboratories Inc

31.4. QIAGEN N.V.

31.5. Evotec SE

31.6. Shanghai ChemPartner Co. Ltd.

31.7. Aragen Life Sciences Limited

31.8. GenScript Biotech Corporation

31.9. BGI Genomics Co. Ltd.

31.10. NeoGenomics Laboratories Inc

31.11. ARUP Laboratories

31.12. Syngene International Limited

31.13. BioDuro-Sundia

31.14. Ambry Genetics Corporation

31.15. Selvita

32. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking

33. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cancer Immunotherapy Drug Discovery Outsourcing Market

35. Cancer Immunotherapy Drug Discovery Outsourcing Market Future Outlook and Potential Analysis

35.1 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2028 - Countries Offering Most New Opportunities

35.2 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2028 - Segments Offering Most New Opportunities

35.3 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Thermo Fisher Scientific Inc. Financial Performance

Table 75: Danaher Corporation Financial Performance

Table 76: Laboratory Corporation of America Holdings (LabCorp) Financial Performance

Table 77: Eurofins Scientific SE Financial Performance

Table 78: WuXi AppTec Co Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Thermo Fisher Scientific Inc. Financial Performance

Figure 75: Danaher Corporation Financial Performance

Figure 76: Laboratory Corporation of America Holdings (LabCorp) Financial Performance

Figure 77: Eurofins Scientific SE Financial Performance

Figure 78: WuXi AppTec Co Ltd. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Breast Cancer Monoclonal Antibodies Global Market Report 2024 – By Product (Naked Mabs, Conjugated Mabs), By Treatment (Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Therapy), By End-User (Hospitals, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Breast Cancer Drugs Global Market Report 2024 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By End User (Ambulatory, Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Breast Cancer Diagnostics Global Market Report 2024 – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies), By Cancer Type (BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types), By Diagnostic Type (Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies), By End Users (Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bone Cancer Treatment Global Market Report 2024 – By Type (Multiple Myeloma, Osteosarcoma, Chondrosarcoma, Ewing Sarcoma), By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Surgery, Other Treatment Types), By Distribution Channel (Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Blood Cancer Drugs Global Market Report 2024 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bladder Cancer Drugs Global Market Report 2024 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Artificial Intelligence In Cancer Diagnostics Global Market Report 2024 – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types), By Application (Screening And Diagnosis, Tumor Identification, Surveillance, Treatment), By End-User (Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Adrenal Cancer Diagnostics Global Market Report 2024 – By Test (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy), By Treatment (Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, Other Treatments), By Tumor Type (Pheochromocytoma, Adrenal Cortical Carcinoma, Other Types), By End-User (Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the cancer immunotherapy drug discovery outsourcing market?

How will the cancer immunotherapy drug discovery outsourcing market drivers and restraints affect the cancer immunotherapy drug discovery outsourcing market dynamics? What forces will shape the cancer immunotherapy drug discovery outsourcing industry goin

The cancer immunotherapy drug discovery outsourcing market major growth driver - High R&D Costs Fueling Growth in Cancer Immunotherapy Drug Discovery Outsourcing Market. For further insights on the cancer immunotherapy drug discovery outsourcing market, request a sample here

What is the forecast market size or the forecast market value of the cancer immunotherapy drug discovery outsourcing market?

The cancer immunotherapy drug discovery outsourcing market size has grown rapidly in recent years. It will grow from $1.35 billion in 2023 to $1.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing cases of adverse drug reactions, increasing demand for comprehensive genomic testing, increasing global incidence of cancer, a growing need for targeted therapy, and a growing number of clinical trials. The cancer immunotherapy drug discovery outsourcing market size is expected to see rapid growth in the next few years. It will grow to $2.31 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to the rising importance of personalized medicine, increasing diagnostic tests, increasing focus on personalized cancer therapy, increasing healthcare expenditure, and increasing cancer incidence and awareness. Major trends in the forecast period include advancements in diagnostic technologies, next-generation sequencing (NGS), integration of artificial intelligence (AI), liquid biopsy technologies, the development of point-of-care companion diagnostic devices, and innovative testing technologies. For further insights on the cancer immunotherapy drug discovery outsourcing market, request a sample here

How is the cancer immunotherapy drug discovery outsourcing market segmented?

The cancer immunotherapy drug discovery outsourcing market is segmented
1) By Drug Type: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types
2) By Service Type: Target Identification And Validation, Lead Screening And Characterization, Cell-based Assays
3) By Therapeutic Area: Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic AreasFor further insights on the cancer immunotherapy drug discovery outsourcing market, request a sample here

Which region has the largest share of the cancer immunotherapy drug discovery outsourcing market? What are the other regions covered in the report?

North America was the largest region in the cancer immunotherapy drug discovery outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the cancer immunotherapy drug discovery outsourcing market, request a sample here.

Who are the major players in the cancer immunotherapy drug discovery outsourcing market?

What are the key trends in the cancer immunotherapy drug discovery outsourcing market?

Major trend in the cancer immunotherapy drug discovery outsourcing market - Strategic Partnerships Driving Cancer Immunotherapy Drug Discovery Outsourcing. For further insights on the cancer immunotherapy drug discovery outsourcing market, request a sample here.

What are the major opportunities in the cancer immunotherapy drug discovery outsourcing market? What are the strategies for the cancer immunotherapy drug discovery outsourcing market?

For detailed insights on the major opportunities and strategies in the cancer immunotherapy drug discovery outsourcing market, request a sample here.

How does the cancer immunotherapy drug discovery outsourcing market relate to the overall economy and other similar markets?

For detailed insights on cancer immunotherapy drug discovery outsourcing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cancer immunotherapy drug discovery outsourcing industry?

For detailed insights on the mergers and acquisitions in the cancer immunotherapy drug discovery outsourcing industry, request a sample here.

What are the key dynamics influencing the cancer immunotherapy drug discovery outsourcing market growth? SWOT analysis of the cancer immunotherapy drug discovery outsourcing market.

For detailed insights on the key dynamics influencing the cancer immunotherapy drug discovery outsourcing market growth and SWOT analysis of the cancer immunotherapy drug discovery outsourcing industry, request a sample here.